Pluri Inc. (PLUR) Discusses Commercialization Strategy, ZEO ScientifiX Transaction and Financial Flexibility Transcript

What happened: Pluri Inc. (PLUR) held a webinar updating investors on its commercialization strategy and its transaction with U.S.-based ZEO ScientifiX, announced earlier that week. Why it matters: Management said the call was meant to convey how it sees Pluri and what will happen at the company in the coming year, covering two important activities. Key numbers: The webinar was dated October 29, 2026. Pluri cites 2 decades in regenerative medicine and cell therapy and 2 Phase III studies in the U.S. and Europe.

Pluri Inc. (PLUR) held a webinar updating investors on its commercialization strategy and its transaction with U.S.-based ZEO ScientifiX, announced earlier that week.

Management said the call was meant to convey how it sees Pluri and what will happen at the company in the coming year, covering two important activities. Key numbers: The webinar was dated October 29, 2026. Pluri cites 2 decades in regenerative medicine and cell therapy and 2 Phase III studies in the U.S. and Europe.